Silence Therapeutics plc
For the period ended Dec 31, 2025. Filed Mar 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 5, 2026
SLN$19.79+0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
7. Other income, net
| Year ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| $000s | $000s | |
| Bank interest receivable | 15 | 704 |
| Accretion on U.S. Treasury Bills | 3,465 | 3,768 |
| Total other income | 3,480 | 4,472 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.